Evaluation of the effectiveness and impact of BBSRC’s investments in antimicrobial resistance research (PDF)
If you cannot open or read this document, you can ask for a different format.
Bioscience research has the potential to make a critical contribution to addressing antimicrobial resistance (AMR). The Biotechnology and Biological Sciences Research Council (BBSRC) currently invests approximately £30 million per annum across a variety of investment mechanisms.
This document summarises the views and 5 key conclusions of a specialist evaluation panel, who conducted an independent evaluation of the effectiveness and impact of BBSRC’s investments in AMR research.